| |
|
| |
|
| |
|
| |
|
| Merck says key Fosamax lawsuit dismissed | | Washington Post - 12 Hours ago | | WHITEHOUSE STATION, N.J. -- Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction. | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| Chain drug retailing's events of the year | | Chain Drug Review - 92 Minutes ago | | With 2009 winding down, the time has come to list the most memorable events of the year in chain drug retailing. Herewith, seven such events: â?¢ The remaking of Walgreens. Seldom in the annals of chain | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| Merck Serono Extends Chinese Footprint | | Pharmaceutical Technology - 12 Hours ago | | Merck Serono has announced plans to extend its global research and development footprint in China by investing more than â?¬150m and building an R&D centre in Beijing. The centre will lead drug development | | | | Add Comment |
|
|
|
| Positive Results for Genta's Leading Oncology Drug | | Pharmaceutical Technology - 12 Hours ago | | Genta has announced its lead oncology product Genasense shows a high response rate when administered as an intravenous infusion for the treatment of advanced melanoma. Preliminary results of a pilot study | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| E. Steven Bauer, 85, pharmaceutical executive | | Philadelphia Inquirer - 17 Hours ago | | E. Steven Bauer, 85, formerly of Chestnut Hill, a retired pharmaceutical executive, died Nov. 14 at the Hill at Whitemarsh, a retirement community, of complications from surgery. At 15, Mr. Bauer left | | | | Add Comment |
|
|